Rheumatoid Arthritis

FDA Approves Intravenous, Subcutaneous Tocilizumab Biosimilar for Autoimmune Conditions

Rebecca AraujoRheumatoid Arthritis | March 19, 2024

The FDA has approved tocilizumab-aazg for the treatment of rheumatoid arthritis, among other diseases.

CD19 CAR T-Cell Therapy in Autoimmune Diseases

Mithu Maheswaranathan, MDRheumatoid Arthritis | March 6, 2024

A case series presented data on the efficacy of CAR T-cell treatment in patients with rheumatic autoimmune disease.

Are CVD Risk Factors Associated With Rheumatoid Arthritis Treatment Failure?

Rebecca AraujoRheumatoid Arthritis | November 27, 2023

Having multiple risk factors for cardiovascular disease may increase the risk of rheumatoid arthritis treatment failure.

Reduced Use of Tofacitinib for US Veterans With RA, Cardiovascular Comorbidities

Rebecca AraujoRheumatoid Arthritis | November 9, 2023

Recent safety data significantly impacted prescribing practices for advanced RA therapies among physicians treating veterans.

Predictors of Inflammatory Arthritis Among Rheumatology Referrals

Mithu Maheswaranathan, MDRheumatoid Arthritis | October 11, 2023

A study sought to identify variables distinguishing inflammatory from noninflammatory arthritis in a large cohort.

$Abatacept Potentially Optimal for Refractory Rheumatoid Arthritis$

Abatacept Potentially Optimal for Refractory Rheumatoid Arthritis

Patrick DalyRheumatoid Arthritis | July 26, 2023

Abatacept improved outcomes for rheumatoid arthritis refractory to methotrexate or TNFi versus rituximab or tocilizumab.

Expert Interviews on Rheumatoid Arthritis

DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.

Get the latest medical updates and insights straight to your inbox.